Deutsche Bank analyst Pito Chickering lowered the firm’s price target on Acadia Healthcare (ACHC) to $20 from $33 and keeps a Buy rating on the shares. The company in a regulatory filing reduced its 2025 EBITDA guidance by 7.5% due to a $49M increase in its expectations for 2025 professional and general liability reserves expense, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare Stock (ACHC) Plunges on Guidance Cut
- Closing Bell Movers: Marvell up 11%, reversing initial earnings selloff
- Acadia Healthcare down 24% at $12.50 after cutting FY25 guidance
- Acadia Healthcare cuts FY 25 EPS view to $1.94-$2.04 from $2.35-$2.45
- Acadia Healthcare Updates 2025 Fiscal Year Guidance